Rare ebola outbreak in Ituri and African response ^{CEFR B2}

In early May 2026 health authorities reported a serious illness cluster in Ituri Province. Scientists at the Institut National de Recherche Biomédicale (INRB) in Kinshasa analysed blood samples, identified the pathogen and within days diagnosed Bundibugyo ebolavirus. This rare strain had been recorded in Uganda in 2007 and in the Isiro area of the DRC in 2012.

The swift laboratory identification underpinned the broader response. The 2014–2016 West Africa epidemic prompted substantial investments in African capacity and led to the establishment of the Africa Centres for Disease Control and Prevention (Africa CDC) in 2016. Africa CDC now coordinates national laboratory strengthening, epidemiology training and genomic sequencing networks. When WHO declared a Public Health Emergency of International Concern on 17 May, Africa CDC declared a Public Health Emergency of Continental Security the next day and mobilised rapid response systems and cross-border coordination. Researchers from Stellenbosch University and other African institutions joined the scientific response.

At the 11th CelebrateLAB West Africa Conference in Monrovia in late May, Africa CDC launched a therapeutic repurposing initiative to speed African-led research into diagnostics, treatments and drug discovery. By mid-June donors had pledged US$ 910 million, exceeding the US$518 million sought in the joint Africa CDC and WHO response plan launched on 5 June. Philanthropies, WHO, the EU and bilateral partners provided catalytic support, while organisations such as the African Population and Health Research Center and the Countdown to 2030 initiative work across many countries. Negotiations on the Pathogen Access and Benefit-Sharing annex to the WHO Pandemic Agreement continue, with an outcome expected in 2027. Sustained, predictable investment in African scientific capacity and preparedness would make outbreaks easier to contain and improve global health security.